The use of plants for medicinal purposes dates back thousands of years but genetic
engineering of plants to produce desired biopharmaceuticals is much more recent. As the …

The use of whole plants for the synthesis of recombinant proteins has received a great deal
of attention recently because of advantages in economy, scalability and safety compared …

The concept of using plants to produce high‐value pharmaceuticals such as vaccines is 20
years old this year and is only now on the brink of realisation as an established technology …

Molecular farming is the production of pharmaceutically important and commercially
valuable proteins in plants. Its purpose is to provide a safe and inexpensive means for the …

Foreign proteins synthesised by plants are now in the marketplace, and clinical trials for
plant-derived therapeutic proteins are underway. Economic analysis of plant production …

Numerous reports have been published over the last decade assessing the potential of
plants as useful hosts for the heterologous expression of clinically useful proteins …

The production of recombinant proteins is one of the major successes of biotechnology.
Animal cells are required to synthesize proteins with the appropriate post-translational …

The potential of plant cells to produce functional recombinantantibodies has been
demonstrated in a number of different plant systems. Wepresent a comparative study of a …

Various forms of recombinant monoclonal antibodies are being used increasingly, mainly for
therapeutic purposes. This review specifically focuses on what is now called antibody …

Antibodies represent a large proportion of therapeutic drugs currently in development. In
most cases, they are produced in mammalian cell lines or transgenic animals because these …